Explore our newsroom for Symani press releases, news stories, and journalist resources.
Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields

MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.

MMI Raises $110 Million in Series C Financing

Micro Instruments, Massive Impact: The Surgibots Podcast featuring The Symani Surgical System

Medical Innovation Must Shift Focus from Common Problems to Unsolvable Ones

MMI and ab medica Partner to Expand Access to Symani® Surgical System

MMI to Present at the 42nd Annual J.P. Morgan Healthcare Conference

‘Under the Microscope’ highlights the promise of robotic-assisted microsurgery for breast cancer reconstruction

MMI Expands Global Footprint with Entry into Asia Pacific Market

MMI’s Symani® Robotic Surgical System Surpasses 500 Clinical Procedures

MMI Named One of Fast Company’s 2023 “World’s Most Innovative Companies”

Massimiliano Simi, VP R&D & Co-Founder of MMI: “We aim to revolutionize microsurgery”

Breakthrough Robotic System Promises to Revolutionize Microsurgery
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.